Operating Lease, Right-of-Use Asset of Protara Therapeutics, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Protara Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Protara Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $3,452,000, a 24% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Protara Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,452,000 -$1,062,000 -24% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $3,725,000 -$1,043,000 -22% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $3,992,000 -$1,026,000 -20% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $4,255,000 -$1,009,000 -19% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 $4,514,000 -$1,053,000 -19% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $4,768,000 -$1,039,000 -18% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $5,018,000 -$1,026,000 -17% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $5,264,000 -$1,013,000 -16% 31 Dec 2023 10-K 05 Mar 2025 2024 FY
Q3 2023 $5,567,000 -$939,000 -14% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $5,807,000 -$924,000 -14% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $6,044,000 -$909,000 -13% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $6,277,000 -$894,000 -12% 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q3 2022 $6,506,000 -$907,000 -12% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $6,731,000 -$917,000 -12% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $6,953,000 +$5,916,000 +570% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $7,171,000 +$6,111,000 +577% 31 Dec 2021 10-K 08 Mar 2023 2022 FY
Q3 2021 $7,413,000 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $7,648,000 +$7,263,919 +1891% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $1,037,000 +$645,481 +165% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $1,060,000 31 Dec 2020 10-K 09 Mar 2022 2021 FY
Q2 2020 $384,081 +$316,081 +465% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $391,519 +$256,519 +190% 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q2 2019 $68,000 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $135,000 31 Mar 2019 10-Q 08 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.